Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jordan

Showing results (471-480 of 508) with videos related to

Pageof 51
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosisH I McFarland, A A Lobito, M M Johnson, et al.
Pediatrics|November 23, 2021
Single-Examination Risk Prediction of Severe Retinopathy of PrematurityAaron S Coyner, Jimmy S Chen, Praveer Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
International Journal of Radiation Oncology, Biology, Physics|September 23, 2008
Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3)Georg A Bjarnason, Robert G Mackenzie, Abdenour Nabid, et al.
American Journal of Preventive Medicine|September 24, 2021
Evaluation of a Pharmacists' Patient Care Process Approach for HypertensionMark D Rivera, Mihaela Johnson, Hae Mi Choe, et al.
ESMO Open|March 4, 2023
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicinesG Zarkavelis, A L Amylidi, C Verbaanderd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2020
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-upP Roth, A Pace, E Le Rhun, et al.
Pageof 51

Showing results (471-480 of 508) with videos related to

Sort By:
Pageof 51
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosisH I McFarland, A A Lobito, M M Johnson, et al.
Pediatrics|November 23, 2021
Single-Examination Risk Prediction of Severe Retinopathy of PrematurityAaron S Coyner, Jimmy S Chen, Praveer Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
International Journal of Radiation Oncology, Biology, Physics|September 23, 2008
Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3)Georg A Bjarnason, Robert G Mackenzie, Abdenour Nabid, et al.
American Journal of Preventive Medicine|September 24, 2021
Evaluation of a Pharmacists' Patient Care Process Approach for HypertensionMark D Rivera, Mihaela Johnson, Hae Mi Choe, et al.
ESMO Open|March 4, 2023
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicinesG Zarkavelis, A L Amylidi, C Verbaanderd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2020
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-upP Roth, A Pace, E Le Rhun, et al.
Pageof 51